Polyadenylic polyuridylic acid

Drug Profile

Polyadenylic polyuridylic acid

Alternative Names: BN 52101; PolyA PolyU; Polyadenur

Latest Information Update: 04 Nov 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ipsen
  • Class Antineoplastics; Polyribonucleotides; Small molecules
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Breast cancer; Gastric cancer; Hepatitis B; HIV infections

Most Recent Events

  • 04 Nov 2002 No development reported - Phase-II for Breast cancer in Spain (IV)
  • 04 Nov 2002 No development reported - Phase-II for Gastric cancer in South Korea (IV)
  • 04 Nov 2002 No development reported - Phase-II for Hepatitis B in South Korea (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top